Cleared Traditional

DIGI TROL TM-RX & DIGI TROL TM-TX (K770411) - FDA 510(k) Clearance

Class I Toxicology device.

K770411 · Nuclear Medical Laboratories, Inc. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1977
Decision
12d
Days
Class 1
Risk

K770411 is an FDA 510(k) clearance for the DIGI TROL TM-RX & DIGI TROL TM-TX. Classified as Digoxin Control Serum, Ria (product code DMP), Class I - General Controls.

Submitted by Nuclear Medical Laboratories, Inc. (Mchenry, US). The FDA issued a Cleared decision on March 16, 1977 after a review of 12 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3280 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Nuclear Medical Laboratories, Inc. devices

Submission Details

510(k) Number K770411 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 04, 1977
Decision Date March 16, 1977
Days to Decision 12 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
75d faster than avg
Panel avg: 87d · This submission: 12d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code DMP Digoxin Control Serum, Ria
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.3280
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.